FR2692269B1 - Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline. - Google Patents

Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.

Info

Publication number
FR2692269B1
FR2692269B1 FR9207258A FR9207258A FR2692269B1 FR 2692269 B1 FR2692269 B1 FR 2692269B1 FR 9207258 A FR9207258 A FR 9207258A FR 9207258 A FR9207258 A FR 9207258A FR 2692269 B1 FR2692269 B1 FR 2692269B1
Authority
FR
France
Prior art keywords
immunogenic
diagnosis
sharp
strain
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9207258A
Other languages
English (en)
Other versions
FR2692269A1 (fr
Inventor
Gian-Franco Pancino
Pierre Sonigo
Colombe Chappey
William Saurin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9207258A priority Critical patent/FR2692269B1/fr
Priority to FR9214026A priority patent/FR2692270A1/fr
Priority to DE69333636T priority patent/DE69333636T2/de
Priority to EP93401538A priority patent/EP0577458B1/fr
Priority to AT93401538T priority patent/ATE278018T1/de
Publication of FR2692269A1 publication Critical patent/FR2692269A1/fr
Application granted granted Critical
Publication of FR2692269B1 publication Critical patent/FR2692269B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
FR9207258A 1992-06-16 1992-06-16 Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline. Expired - Lifetime FR2692269B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9207258A FR2692269B1 (fr) 1992-06-16 1992-06-16 Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR9214026A FR2692270A1 (fr) 1992-06-16 1992-11-23 Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
DE69333636T DE69333636T2 (de) 1992-06-16 1993-06-16 Nukleotid- und Peptidsequenzen des Immunschwächevirus der Katze, Isolat WO und Anwendungen der Sequenzen in der Diagnostik und zur Verhinderung der Infektion
EP93401538A EP0577458B1 (fr) 1992-06-16 1993-06-16 Séquences nucléotidiques et peptidiques issues de la souche Wo du VIF et applications desdites séquences au diagnostic et à la prévention de l'immunodéficience féline
AT93401538T ATE278018T1 (de) 1992-06-16 1993-06-16 Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9207258A FR2692269B1 (fr) 1992-06-16 1992-06-16 Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.

Publications (2)

Publication Number Publication Date
FR2692269A1 FR2692269A1 (fr) 1993-12-17
FR2692269B1 true FR2692269B1 (fr) 1995-05-19

Family

ID=9430778

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9207258A Expired - Lifetime FR2692269B1 (fr) 1992-06-16 1992-06-16 Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.

Country Status (1)

Country Link
FR (1) FR2692269B1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.

Also Published As

Publication number Publication date
FR2692269A1 (fr) 1993-12-17

Similar Documents

Publication Publication Date Title
ATE98546T1 (de) Arbeitszange.
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
HU891055D0 (en) Ultrasonic contrast materials, process for their preparation and for their use as diagnostical and therapeutical drugs
TR199501021A2 (tr) Vücut agirligi modülatörüne tekabül eden nükleik asitler ve proteinler ve bunlarin diagnostik ve terapötik kullanimlari.
TR199600873A2 (tr) Ikame edilmis sülfonimidamid'ler, bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve ayrica bunlari ihtiva eden ilaclar.
CZ2000806A3 (cs) Demonstrační zařízení ve tvaru živého tvora
CA2192512A1 (fr) Anticorps monoclonal nmo3; methodes d'utilisation
ATE208630T1 (de) Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen
TR199600612A2 (tr) Ikame edilmis sinamikasitguanidid'leri bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve ayrica bunlari ihtiva eden ilaclar.
DZ452A1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-paptide humain.
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
FR2692269B1 (fr) Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR2681777B1 (fr) Clou chirurgical implantable dans l'os.
FR2651505B1 (fr) Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments.
FR2698367B1 (fr) Fragments de la protéine p53 et leurs utilisations dans la détection et le suivi d'états pathologiques.
RU94002476A (ru) Лекарственное средство
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
FR2752425B1 (fr) Fragments d'acides nucleiques specifiques de mycobacteries membres du complexe m. tuberculosis et leurs applications pour la detection et le diagnostic differentiel des membres du complexe m. tuberculosis
FR2684552B1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
FR2692279B1 (fr) Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
TR199600588A2 (tr) 4-Floralkil ikame edilmis benzoilguanidin'ler, bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve bunlari ihtiva eden ilaclar.
FR2721577B1 (fr) Machine à locomotion mue par la marche de l'homme.
CA2239420A1 (fr) Compositions destinees a la prevention et au traitement de troubles gastro-intestinaux et comprenant du bismuth ainsi qu'un ou plusieurs agents antimicrobiens
FR2699805B1 (fr) Agencement d'aide au diagnostic médical.
FI861093A0 (fi) Bioelektrisk patientmonitor.